Represented H. Lundbeck A/S and Lundbeck Canada Inc. in applications to prohibit the Minister of Health from issuing notices of compliance which would allow the sale, by the client, of a generic version of citalopram hydrobromide (CELEXA).
Click to view a full description of the case: Genpharm Inc . v. Canada (Minister of Health) (F.C.), 2003 FC 1148, (2003), [2004] 1 F.C.R. 375